3.0
Jan 2, 2022
Recommend
CEO approval
Business Outlook
Pros
Benefits are solid; very nice colleagues and a supportive team/manager
Cons
morale is not good; people leaving in droves for better opportunities and before possibly being laid off; press writes daily about BIOGEN and not good. Chief medical officer “retired”, lots of cost cutting expected in 2022